Insider · CIK 0001276038
Gino Santini
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC), CMPS (COMPASS Pathways plc). First filing Aug 19, 2025, latest Aug 19, 2025.
Gino Santini files SEC Form 4 as director at COLL (COLLEGIUM PHARMACEUTICAL, INC), and also at CMPS (COMPASS Pathways plc). Since Aug 19, 2025, Gino Santini has reported 0 open-market buys worth $0 and 1 open-market sell worth $201k, the latest filed on Aug 19, 2025.
A track record needs three past buys with six months of prices behind them; Gino Santini has 0, so none is measured yet.
The newest scored trade: sold $201k of COLL on Aug 15, 2025, filed Aug 19, 2025, scored 27 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
COLL: COLLEGIUM PHARMACEUTICAL, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | COLLEGIUM PHARMACEUTICAL, INC | $201k 5,405 shares | -5% | +53% from low-10% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 5,405 0.02% of outstanding | $201k | Aug 15, 2025 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Common Stock | +8,700 | $16.49 | $143k | 112,483 | Jun 10, 2026 |
| Jun 8, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Stock Option (Right to Purchase)derivative | -8,700 | $0.00 | $0 | 0 | Jun 10, 2026 |
| May 27, 2026 | CMPS COMPASS Pathways plc | AGrant or award Share Option (Right to Buy)derivative | +30,158 | $0.00 | $0 | 30,158 | May 29, 2026 |
| May 14, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +8,741 | $0.00 | $0 | 103,783 | May 18, 2026 |
| Aug 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Common Stock | +15,000 | $13.45 | $202k | 100,447 | Aug 19, 2025 |
| Aug 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock | -5,405 | $37.19 | $201k | 95,042 | Aug 19, 2025 |
| Aug 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Stock Option (Right to Purchase)derivative | -15,000 | $0.00 | $0 | 0 | Aug 19, 2025 |
| Jun 12, 2025 | CMPS COMPASS Pathways plc | AGrant or award Share Option (Right to Buy)derivative | +39,000 | $0.00 | $0 | 39,000 | Jun 13, 2025 |
| May 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +9,791 | $0.00 | $0 | 85,447 | May 19, 2025 |
Questions about Gino Santini
Answered from the filings on this page, as of the latest one.
Is Gino Santini buying or selling?
Not in the last 12 months. Gino Santini's latest open-market trade on SEC Form 4 was sold $201k of COLL on Aug 15, 2025.
How did Gino Santini's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gino Santini has 0.
Where does Gino Santini file Form 4?
Gino Santini has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC); CMPS (COMPASS Pathways plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.